Results 121 to 130 of about 19,601 (263)

Impact of the pancreatic enzyme replacement therapy (PERT) shortage on prescribing in England: Analysis of national data

British Journal of Clinical Pharmacology, EarlyView.
Aim Pancreatic enzyme replacement therapy (PERT) is essential for the management of pancreatic exocrine insufficiency. Since June 2023, the United Kingdom has been affected by a global shortage of PERT. We investigated the impact of this shortage on national prescribing trends for Creon, Nutrizym, Pancrex and Pangrol.
Teena S. Varghese, Mary E. Phillips, Louis Fisher, Helen Fitt, Adam Frampton, Christopher Wood, Agnieszka Lemanska   +6 more
wiley   +1 more source

Mechanisms and Therapeutic Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure. [PDF]

Rev Cardiovasc Med
Huang Z, Ling G, Fang C, Wu Z, Ye S, Zhang C, Luo C, Zheng B.   +7 more
europepmc   +1 more source

‘…It was my choice to see how I can acquire this Western world education… and I'm happy…’: Structuration and the dialectic nature of being a Nigerian university student in the UK

British Educational Research Journal, EarlyView.
Abstract This paper examines the experiences of Nigerian cross‐border students in UK higher education, focusing on how colonial legacies continue to shape the interplay between structure and agency. Three key themes emerged in the analysis of the data: First, the persistence of a ‘West is Best’ mentality reflects the internalisation of colonial ...
Jennifer Marshall, Jack Bryne Stothard
wiley   +1 more source

Uniform efficacy of SGLT2 inhibitors across the ejection fraction spectrum and in high-risk patients with HFpEF: a prespecified pooled analysis. [PDF]

Front Cardiovasc Med
Xue X, Yu Z, Dai M, Zhang T.
europepmc   +1 more source

Reframing Colonial Korea's Forests Through Protection Forests: The Forests of Joseon (1938)

Berichte zur Wissenschaftsgeschichte, EarlyView.
This study examines The Forests of Joseon (1938), a forestry survey compiled by Tokumitsu Nobuyuki under Japanese colonial rule, as a key site of epistemic negotiation between imperial forestry science and Korean indigenous knowledge. Focusing on bíbo forests—geomantic forests believed to regulate energy flow between mountains and villages—the paper ...
Soyeong Park, Jeong‐Hann Pae
wiley   +1 more source

Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled. [PDF]

JACC Adv
Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Pfarr E, Gasior T, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M, Verma S, EMPEROR-Pooled Trial Committees and Investigators.   +13 more
europepmc   +1 more source

Understanding Plant Parasitism: Hydnora Africana and European Scientific Practice in the Early Nineteenth Century**

Berichte zur Wissenschaftsgeschichte, EarlyView.
This article will analyze the uncertainties around collecting and classifying Hydnora africana in the first half of the nineteenth century. Emerging from the distinctive dryland ecologies of South Africa, Hydnora was interpreted as strange and cryptic by Europeans primarily because it is a root parasite—a complex floral trait that was little understood.
Katherine Arnold
wiley   +1 more source

Lunar and seasonal patterns of a longnose emperor spawning aggregation in Palau. [PDF]

Sci Rep
Muller Karanassos C, Mesengei M, Barriuso R, Claassens L, Sartori G, Nestor V, Biondi P, Krueck NC, Wolfe B, Marshell A.   +9 more
europepmc   +1 more source

Nonhuman Mobilities and Multispecies Border Regimes in (Post‐)Colonial Southern Africa**

Berichte zur Wissenschaftsgeschichte, EarlyView.
This article explores how borders in Southern Africa—such as Namibia's internal veterinary and settler border (Red Line) and national borders between Namibia, South Africa, and Botswana—functioned not only as territorial dividers but as tools to shape colonial and postcolonial multispecies hierarchies. These borders regulated human and animal movement,
Luregn Lenggenhager
wiley   +1 more source

Gliflozins in Practice: Real-Life Use of Dapagliflozin and Empagliflozin in HFrEF Versus Clinical Trial Data. [PDF]

Diagnostics (Basel)
Mapelli M, Caputo R, Valenti M, Rubbo FM, Salvioni E, Mattavelli I, Galotta A, Piotti A, Puttini F, Manfrin L, Vignati C, Costantino S, Agostoni P.   +12 more
europepmc   +1 more source